InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Limbek Andrew, Chief Executive Officer. Insider active across 2 companies, notably PSYCHEMEDICS CORP. Aggregated, 6 filings have been logged. Activity tracked since 13 May 2021. The latest transaction was filed on 20 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
7,000 shares0Common Stock, $.005 Par ValueSEC:0001843082-22-000024:0
600 shares@ US$6.440.025% mcap93.9% of flowCommon Stock, $.005 Par ValueSEC:0001843082-22-000013:0
37 shares@ US$7.390.0016% mcap6.1% of flowCommon Stock, $.005 Par ValueSEC:0001843082-22-000002:0
37 shares@ US$7.390.0016% mcap100.0% of flowCommon Stock, $.005 Par ValueSEC:0001843082-22-000002
6,000 shares0Common Stock, $.005 Par ValueSEC:0001843082-21-000013
6,000 shares0Common Stock, $.005 Par ValueSEC:0001843082-21-000013:0
6 of 6 declarations
About Limbek Andrew
Andrew Limbek is Chief Executive Officer, Vice President, and Controller at Psychemedics Corp. He is responsible for the strategic direction of the company, overseeing financial and accounting operations. With a strong background in the sector, Andrew plays a key role in the growth and innovation of the company. He is committed to achieving the long-term objectives of Psychemedics.
